443 related articles for article (PubMed ID: 26187902)
21. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome.
Moran LJ; Noakes M; Clifton PM; Tomlinson L; Galletly C; Norman RJ
J Clin Endocrinol Metab; 2003 Feb; 88(2):812-9. PubMed ID: 12574218
[TBL] [Abstract][Full Text] [Related]
22. Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training.
Joham AE; Teede HJ; Hutchison SK; Stepto NK; Harrison CL; Strauss BJ; Paul E; Watt MJ
Obesity (Silver Spring); 2012 Dec; 20(12):2390-6. PubMed ID: 22641183
[TBL] [Abstract][Full Text] [Related]
23. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
25. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
26. Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.
Kupreeva M; Diane A; Lehner R; Watts R; Ghosh M; Proctor S; Vine D
Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E16-E33. PubMed ID: 30153063
[TBL] [Abstract][Full Text] [Related]
27. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats.
Rohner-Jeanrenaud F; Craft LS; Bridwell J; Suter TM; Tinsley FC; Smiley DL; Burkhart DR; Statnick MA; Heiman ML; Ravussin E; Caro JF
Int J Obes Relat Metab Disord; 2002 Feb; 26(2):143-9. PubMed ID: 11850744
[TBL] [Abstract][Full Text] [Related]
28. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.
Thomson RL; Buckley JD; Brinkworth GD
Obes Rev; 2011 May; 12(5):e202-10. PubMed ID: 20546140
[TBL] [Abstract][Full Text] [Related]
29. The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome.
Barber TM; Vojtechova P; Franks S
Horm Mol Biol Clin Investig; 2013 Sep; 15(3):91-103. PubMed ID: 25436736
[TBL] [Abstract][Full Text] [Related]
30. The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome.
Thomson RL; Brinkworth GD; Noakes M; Clifton PM; Norman RJ; Buckley JD
Hum Reprod; 2012 Jul; 27(7):2169-76. PubMed ID: 22552687
[TBL] [Abstract][Full Text] [Related]
31. Modulatory role of food, feeding regime and physical exercise on body weight and insulin resistance.
Kretschmer BD; Schelling P; Beier N; Liebscher C; Treutel S; Krüger N; Scholz HP; Haus A
Life Sci; 2005 Feb; 76(14):1553-73. PubMed ID: 15680166
[TBL] [Abstract][Full Text] [Related]
32. Effects of prepubertal-onset exercise on body weight changes up to middle age in rats.
Shindo D; Matsuura T; Suzuki M
J Appl Physiol (1985); 2014 Mar; 116(6):674-82. PubMed ID: 24458753
[TBL] [Abstract][Full Text] [Related]
33. Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.
Ravn P; Haugen AG; Glintborg D
Minerva Endocrinol; 2013 Mar; 38(1):59-76. PubMed ID: 23435443
[TBL] [Abstract][Full Text] [Related]
34. Insulin sensitivity deteriorates after short-term lifestyle intervention in the insulin sensitive phenotype of obesity.
Gilardini L; Vallone L; Cottafava R; Redaelli G; Croci M; Conti A; Pasqualinotto L; Invitti C
Obes Facts; 2012; 5(1):68-76. PubMed ID: 22433619
[TBL] [Abstract][Full Text] [Related]
35. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
36. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
Nybacka Å; Carlström K; Ståhle A; Nyrén S; Hellström PM; Hirschberg AL
Fertil Steril; 2011 Dec; 96(6):1508-13. PubMed ID: 21962963
[TBL] [Abstract][Full Text] [Related]
37. Effects of Exercise Intervention on Preventing Letrozole-Exposed Rats From Polycystic Ovary Syndrome.
Cao SF; Hu WL; Wu MM; Jiang LY
Reprod Sci; 2017 Mar; 24(3):456-462. PubMed ID: 27407136
[TBL] [Abstract][Full Text] [Related]
38. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness of high intensity intermittent training on metabolic, reproductive and mental health in women with polycystic ovary syndrome: study protocol for the iHIT- randomised controlled trial.
Hiam D; Patten R; Gibson-Helm M; Moreno-Asso A; McIlvenna L; Levinger I; Harrison C; Moran LJ; Joham A; Parker A; Shorakae S; Simar D; Stepto N
Trials; 2019 Apr; 20(1):221. PubMed ID: 30992038
[TBL] [Abstract][Full Text] [Related]
40. Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model.
Ressler IB; Grayson BE; Ulrich-Lai YM; Seeley RJ
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1076-84. PubMed ID: 26078189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
